Advanced search
News (96)
Companies (1)
Camil Alimentos SA is a Brazil-based company primarily engaged in the food processing sector. The Company focuses on the manufacture and commercialization of rice, rice crackers, beans, peas, chickpeas and lentil seeds, soybean-based meals, popcorn, sugar ...
Insiders
Dr. Camille L. Bedrosian, MD, is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., a Member at American Society of Clinical Oncology, a Member at American Society of Hematology and a Member at American Society of Nephrology. She is on the Board of Directors at Rhythm Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was previously employed as a Chief Medical Officer & Senior Vice President by Alexion Pharmaceuticals, Inc., a Chief Medical Officer & Vice President by ARIAD Pharmaceuticals, Inc., a Senior Director-Oncology & Hematology by Genetics Institute, Inc., a Member by American Association for Cancer Research, a Member by American Association for the Advancement of Science, a Member by Duke Comprehensive Cancer Center, and an Assistant Professor by Duke University Medical Center. She received her undergraduate degree from Harvard University, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
John C.
Bedrosian is currently a Director at The International Dairy Foods Association, All Star Dairy Foods, Inc., and Dairy Institute of California.
He was formerly a Director at The American Institute of Baking and Vice President-Manufacturing at UNFI Grocers Distribution, Inc. Bedrosian obtained an undergraduate degree from The California State University.
Mr. Bedrosian serves as the Chief Financial Office of Marcus & Millichap Company and is responsible for overseeing the entire finance function, including, capital markets, taxation, and treasury.
He also serves as a member of the Company's Investment Committee.
Mr. Bedrosian has significant experience within the real estate investment banking community and has acted as a strategic advisor to many private and public companies within the sector.
Prior to joining Marcus & Millichap Company, he was the Chief Financial Officer at Ramco-Gershenson Properties Trust, a publically-traded REIT, and served as the Managing Director in the Global Real Estate Investment Banking Group at Deutsche Bank Securities, Inc. Mr. Bedrosian earned a B.S.
in Finance and Administration from Mercy College and an M.S.
in Real Estate and Finance from New York University.
No results for this search
- Stock Market
- Advanced search
- Camille Bedrosian